Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Engelke

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Blood|March 20, 2013
β2 integrin-derived signals induce cell survival and proliferation of AML blasts by activating a Syk/STAT signaling axisThomas Oellerich, Mark F Oellerich, Michael Engelke, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2016
Elucidation of tonic and activated B-cell receptor signaling in Burkitt's lymphoma provides insights into regulation of cell survivalJasmin Corso, Kuan-Ting Pan, Roland Walter, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2026
RHOA controls oncogenic B cell receptor signaling in aggressive lymphomaAriana N Jacobs, Dominique Jahn, Tim Beringer, et al.
Blood|October 8, 2021
SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphomaAnne C Wilke, Carmen Doebele, Alena Zindel, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Blood|March 20, 2013
β2 integrin-derived signals induce cell survival and proliferation of AML blasts by activating a Syk/STAT signaling axisThomas Oellerich, Mark F Oellerich, Michael Engelke, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2016
Elucidation of tonic and activated B-cell receptor signaling in Burkitt's lymphoma provides insights into regulation of cell survivalJasmin Corso, Kuan-Ting Pan, Roland Walter, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2026
RHOA controls oncogenic B cell receptor signaling in aggressive lymphomaAriana N Jacobs, Dominique Jahn, Tim Beringer, et al.
Blood|October 8, 2021
SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphomaAnne C Wilke, Carmen Doebele, Alena Zindel, et al.
Pageof 4